IMCI guidelines (Tanzania) |
Costs of drugs were higher by 61% compared to control districts. Cost of the intervention not included. |
Total drug costs for managing outpatient illness in those aged <5 years. |
|
|
|
Health system costs per child were 44% lower in intervention districts than in control districts. Cost of the intervention was included. |
Total health system costs (including start up and post implementation costs) for managing outpatient illness in those aged <5 years. |
|
Multidisciplinary clinical pathway for oxygen administration |
Led to changes in oxygen prescribing behaviour but consumed more resources than standard management by 116%. Cost of the intervention was included. |
Total health system costs (including start up and post implementation costs). |
|
Multifaceted intervention to improve preventive care delivered by nurses |
Costs decreased by 34%. Cost of the intervention was included. |
Total health system costs (training, Supervision) |
|
Use of commercially available electronic prescribing system with integrated clinical decision support and evidence - based message capability. |
The proportion of prescriptions for high costs drugs that were the target of this intervention to prescribers was a relative 17.5% lower among the intervention group compared with the control group. |
Total drug costs |
|
Multifaceted intervention to promote early switch from intravenous to oral acetaminophen for prospective pain |
Costs decrease by 57%. Cost of the intervention not included. |
Total cost for acetaminophen analgesia costs |
|
Clinical pathways for patients undergoing total laryngectony |
Hospital variable costs decreased by 14.4%
|
Total hospital costs (both fixed and variable costs) |
|
New antibiotics protocol involving amoxicillin as a first line agent. |
Costs decrease by 28%. Cost of the intervention not included. |
Total antibiotics costs |
|
Educational intervention to decrease use of selected expensive medications |
A 32% decrease in use of the more costly anticoagulant and a 20% increase in use of the less costly anticoagulant representing an estimated annual savings of $66000. Cost of the intervention not included. |
Total anti-coagulant costs |
|
Use of clinical pathway designed to manage community acquired pneumonia more efficiently than conventional therapy |
Cost savings of 16%, 24% and 24% from the perspectives: healthcare, government and societal. Cost of the intervention not included. |
Total consumable costs |
|
Guidelines with one to one educational outreach visits by community pharmacists |
Mean costs reduce by 6%. |
Total drug costs including guideline production and dissemination; together with provision of education outreach visits |
|
In patient diabetes management program |
The reduction in length of stay for patients with diabetes has resulted in savings of more than $2 million for the year and has yielded a 467% return on investment for the hospital. |
Total hospital costs |
|
Modeling studies |
Degree of financial saving |
Proportion of total drug costs or total health system costs. |
|
Malaria microscopy (change in clinical practice) |
Costs of prescribed Artemether-Lumefantrine decreased by 54% while that of antibiotics increased by 5%. Therefore, the overall drug cost saving was 49%. Cost of the intervention not included. |
Total Outpatient drug costs |
|
IMCI guidelines (Kenya) |
Cost of treatment reduced by an average of 42%. Cost of the intervention not included. |
Total drug costs for managing outpatient illness in those aged <5 years |
|
IMCI guidelines (Uganda) |
Cost of medication reduced by 80%. Cost of the intervention not included. |
Total drug costs for managing outpatient illness in those aged <5 years |
|
IMCI guidelines (Bangladesh) |
Cost of treatment reduced by 34%. Cost of the intervention not included. |
Total drug costs for managing outpatient illness in those aged <5 years. |